As demonstrated in a melanoma model, an aggressive triple-combination therapy (cyclophosphamide, adoptive CD4+ T cells, and anti-OX40) successfully converted these cells from a pro-tumorigenic to an anti-tumorigenic state [17]. Here, TNFRSF4 is linked to melanoma.